![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 05, 2018 9:09:43 AM
Science Mar 4, 2018 1:52 PM EST
“If this had been a year or two ago we wouldn’t have had this treatment to offer him.” — Dr. Jennifer Willert, UCSF
Six years ago, he was diagnosed with a form of leukemia called Acute Lymphoblastic Leukemia (ALL), which is the most common cancer in children.
HTTPS://www.pbs.org/newshour/science/gene-therapy-was-a-boys-last-chance-to-stop-leukemia-and-it-worked
Shaun is one of at least 50 children who are in remission because of a breakthrough treatment that engineers the body’s own immune system to fight cancer. Last August, the U.S. Food and Drug Administration (FDA) approved the treatment
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM